Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Aronson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The American Journal of Medicine|March 1, 1993
Summary statistics and treatment decisionsF R Aronson
The New England Journal of Medicine|April 6, 1989
Recombinant human GM-CSF in myelosuppression of chemotherapy (continued)M H Bar, F R Aronson
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cellsR P Numerof, F R Aronson, J W Mier
Journal of the National Cancer Institute|September 5, 1990
Insurance coverage for investigational therapyF R Aronson, M L Ernest, M Tasch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cellsO M Martinez, R S Gibbons, M R Garovoy, et al.
Journal of Surgical Oncology|January 1, 1994
Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimensJ S Wolf, F R Aronson, E J Small, et al.
Journal of the National Cancer Institute|January 2, 1991
Life-threatening bullous skin eruptions during interleukin-2 therapyM R Staunton, M C Scully, P E Le Boit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapyJ W Mier, E P Brandon, P Libby, et al.
Pathology and Immunopathology Research|January 1, 1988
Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cellsJ W Mier, F R Aronson, R P Numerof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injuryF R Aronson, P Libby, E P Brandon, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The American Journal of Medicine|March 1, 1993
Summary statistics and treatment decisionsF R Aronson
The New England Journal of Medicine|April 6, 1989
Recombinant human GM-CSF in myelosuppression of chemotherapy (continued)M H Bar, F R Aronson
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1988
IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cellsR P Numerof, F R Aronson, J W Mier
Journal of the National Cancer Institute|September 5, 1990
Insurance coverage for investigational therapyF R Aronson, M L Ernest, M Tasch, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1990
IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cellsO M Martinez, R S Gibbons, M R Garovoy, et al.
Journal of Surgical Oncology|January 1, 1994
Nephrectomy for metastatic renal cell carcinoma: a component of systemic treatment regimensJ S Wolf, F R Aronson, E J Small, et al.
Journal of the National Cancer Institute|January 2, 1991
Life-threatening bullous skin eruptions during interleukin-2 therapyM R Staunton, M C Scully, P E Le Boit, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1989
Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapyJ W Mier, E P Brandon, P Libby, et al.
Pathology and Immunopathology Research|January 1, 1988
Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cellsJ W Mier, F R Aronson, R P Numerof, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1988
IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injuryF R Aronson, P Libby, E P Brandon, et al.
Pageof 3